Platelet amyloid precursor protein forms in AD: A peripheral diagnostic tool and a pharmacological target

Mechanisms of Ageing and Development

Volumn 122, Issue 16, 2001, Pages 1997-2004

  Padovani, Alessandro ^a   Borroni, Barbara ^a   Colciaghi, Francesca ^a   Pastorino, Lucia ^a   Archetti, Silvana ^b   Cottini, Elisabetta ^a   Caimi, Luigi ^a   Cattabeni, Flaminio ^a   Di Luca, Monica ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b SPEDALI CIVILI   (Italy)

Author keywords

Alzheimer; Amyloid precursor protein; Biomarker; Platelets

Indexed keywords

AMYLOID PRECURSOR PROTEIN; DONEPEZIL;

ALZHEIMER DISEASE; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; PARENCHYMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; THROMBOCYTE; TREATMENT OUTCOME;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; BIOLOGICAL MARKERS; BLOOD PLATELETS; CHOLINESTERASE INHIBITORS; HUMANS; INDANS; PIPERIDINES;

EID: 0034811885     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(01)00315-3     Document Type: Conference Paper

References (57)

1. Cerebrospinal fluid β-amyloid (1-42) in Alzheimer disease. Difference between early and late-onset Alzheimer disease and stability during the course of disease
2. Tau in the cerebrospinal fluid: A potential diagnostic marker in Alzheimer's disease
3. Amyloid precursor protein (APP) and β4 amyloid in the etiology of Alzheimer's disease: Precursor product relationships in the derangement of neuronal function
4. Tau protein in cerebrospinal fluid. A biochemical marker for axonal degeneration in Alzheimer's disease?
5. Amyloid precursor protein in platelets of patients with Alzheimer's Disease. Effect of acetylcholinesterase inhibitor treatment
6. Neuropathological staging of Alzheimer-related changes
7. The amyloid precursor protein of Alzheimer's disease is released by human platelets
8. Evidence that tumor necrosis factor alpha-converting enzyme is involved in regulated alfa-secretase cleavage of the Alzheimer amyloid precursor protein
9. Platelets are the primary source of amyloid β-peptide in human blood
10. Stimulated platelets release amyloid β-protein precursor
11. The Ronald and Nancy Reagan Research Institute of the Alzheimer Association and National Institute on aging on diagnostic criteria for the neuropathological assessment of the Alzheimer's disease
12. Non-age related differences in thrombin responses by platelets from male patients with advanced Alzheimer's disease
13. Activated Alzheimer disease platelets retain more beta amyloid precursor protein
14. Moderate and advanced Alzheimer's patients exhibit platelet activation differences
15. Peripheral markers and diagnostic criteria in Alzheimer's disease: Critical evaluations
16. Abnormal pattern of platelet APP isoforms in Alzheimer disease and Down Syndrome
17. Differential pattern of platelet APP isoforms: An early marker for Alzheimer Disease
18. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician
19. Assessment of cerebrospinal fluid levels of τ in mildly demented patients with Alzheimer's disease
20. Intact Alzheimer amyloid precursor protein (APP) is present in platelet membrane and is encoded by platelet mRNA
21. Characterization of Alzheimer amyloid precursor protein transcripts in platelets and megakaryocytes
22. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease
23. Improved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSF
24. Identification of a novel Aspartic Protease (Asp2) as β-secreatase molecular and cell
25. Longitudinal study of cerebrospinal fluid levels of τ, Abeta1-40, and Abeta1-42(43) in Alzheimer's disease: A study in Japan
26. Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease
27. A novel iron uptake mechanism mediated by GPI-anchored human p97
28. Incorrect diagnosis of Alzheimer disease: A clinicopathologic study
29. Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease
30. Proteolitic processing of Alzheimer's disease β4 amyloid precursor protein in human platelets
31. Amyloid plaque core protein in Alzheimer's disease and Down syndrome
32. Reduction of platelet phospholipase C activity in patients with Alzheimer's disease
33. Reduction of platelet PLC-delta 1 activity in AD associated with a specific apolipoprotein genotype (epsilon 3/epsilon 3)
34. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease
35. Plasma and cerebrospinal fluid levels of amyloid β proteins 1-40 and 1-42 in Alzheimer Disease
36. Clinically diagnosed Alzheimer disease: Neuropathologic findings in 650 cases
37. Validation of clinical diagnostic criteria for Alzheimer disease
38. Reduction of β-amyloid peptide 1-42 in the cerebrospinal fluid of patients with Alzheimer disease
39. Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: Inverse correlation with severity of dementia and effect of apolipoprotein E genotype
40. The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin II
41. Quantitative changes in the amyloid β4 precursor protein in Alzheimer cerebrospinal fluid
42. Cerebrospinal protein tau is elevated in early Alzheimer disease
43. Altered amyloid protein processing in platelets of patients with Alzheimer disease
44. Beta-amyloid precursor protein of Alzheimer's disease occurs as 110- to 135-kilodalton membrane associated proteins in neural and non-neural tissues
45. Alzheimer Disease: A central role for amyloid
46. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluid
47. Platelet activation in Alzheimer disease
48. Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein
49. Biological markers in Alzheimer's disease
50. Amyloid beta Protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus
51. Protease Nexin II (Amyloid β-protein precursor): A platelet β-granule protein
52. Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane Aspertic Protease BACE
53. Elevation of microtubule-associated protein τ in the cerebrospinal fluid of patients with Alzheimer's disease
54. Membrane-anchored aspartyl protease with Alzheimer's disease β secretase activity
55. Platelet membrane abnormality in Alzheimers disease
56. Prospective study of increased platelet membrane fluidity as a risk factor for AD: Results at 5 years